Titlebook: New Aspects of Storage and Release Mechanisms of Catecholamines; Hans-Joachim Schümann (Direktor des Pharmakologisc Book 1970 Springer-Ver

宣告無(wú)效

書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines影響因子(影響力)




書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines影響因子(影響力)學(xué)科排名




書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines被引頻次




書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines被引頻次學(xué)科排名




書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines年度引用




書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines年度引用學(xué)科排名




書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines讀者反饋




書(shū)目名稱New Aspects of Storage and Release Mechanisms of Catecholamines讀者反饋學(xué)科排名

Mettle

Annica Dahlstr?mep of the interpretation process. In order to perform higher-level analysis, a priori information must be incor- rated into the interpretation process. A convenient way of achieving this is to use a ?exible model to encode information such as the expected size, shape, appearance, and position of obj

Arthropathy

E. De Robertisep of the interpretation process. In order to perform higher-level analysis, a priori information must be incor- rated into the interpretation process. A convenient way of achieving this is to use a ?exible model to encode information such as the expected size, shape, appearance, and position of obj

Herd-Immunity

發(fā)起

Jan H?ggendalep of the interpretation process. In order to perform higher-level analysis, a priori information must be incor- rated into the interpretation process. A convenient way of achieving this is to use a ?exible model to encode information such as the expected size, shape, appearance, and position of obj

IDEAS

insidious

U. S. von Eulerively decided which patients received the experimental treatment. Clinical trials often use double blinding whereby neither the patient nor the investigator/physician knows which treatment the patient is receiving. Blinding the patient equalizes the placebo effect—feeling better because one thinks o

Glossy

U. Trendelenburg,P. R. Draskóczy,K.-H. Graefe,H. Hennemann2) two survival distributions under the proportional hazards assumption. In this chapter we discuss the similarities between comparing means and comparing survival distributions using the logrank statistic under the proportional hazards assumption. We then consider survival monitoring when the propo

緊張過(guò)度

小卒

D. Palm,H. Grobecker,I. J. Bakively decided which patients received the experimental treatment. Clinical trials often use double blinding whereby neither the patient nor the investigator/physician knows which treatment the patient is receiving. Blinding the patient equalizes the placebo effect—feeling better because one thinks o